ERASE CDI 2

Prediction of Clostridium difficile colonization in admitted patients.Step 2 of ERASE CDI

November 22, 2017

  • Clinical Trial Information

    Trial Contact: See Principal Investigator

    Trial Phone:

  • IRB No: 15.034.03

    Principal Investigator: Steven G. Rothrock, MD

    Age Group: Adult

  • Objective

    This study will be performed to determine if previously described criteria (ERASE) can predict Clostridium difficile colonization in patients admitted to the hospital and to determine the overall rate.

  • Key Eligibility

    A convenience sample of 300 patients who are admitted to the hospital via the ED aged 18 years old and older will be enrolled.